Skip to main content

Patent litigation in Singapore.

Patent litigation in Singapore. The process involves several steps:

1. Filing a Writ of Summons:

The plaintiff initiates the litigation by filing a Writ of Summons, outlining their claims and relief sought. This officially starts the lawsuit.

2.Serving Court Documents: 

The plaintiff serves the court documents to the defendant, who responds by filing a Memorandum of Appearance to indicate their participation in the case.

3.Pleadings and Statements of Case: 

Both parties exchange their statements of case, including the Statement of Claim by the plaintiff and the Statement of Defence by the defendant. Further statements and counterclaims might also be filed.

4.Case Management Conference (CMC): 

The court schedules a CMC to manage the case's progress, including issues like discovery, evidence, and trial dates.

5.Discovery: 

Each party gathers and discloses relevant documents and evidence that will be used during the trial. This can include expert reports, technical documents, and communication records.

6.Interlocutory Applications: 

If necessary, either party can make applications for interim relief or specific orders from the court to address various aspects of the case.

7.Trial: 

The trial phase involves presenting arguments, evidence, and witnesses before the court. Expert witnesses might be called upon to provide their opinions on technical matters.

8.Judgment: 

After hearing both sides, the judge delivers a judgment, which could involve findings on patent validity, infringement, damages, and other related matters.

9.Appeal: 

If either party is dissatisfied with the judgment, they can appeal to a higher court, such as the Court of Appeal, based on specific legal grounds.

10.Enforcement: 

If the judgment favors the plaintiff, they can take steps to enforce their rights and remedies as determined by the court.

Singapore's Intellectual Property (IP) Court, part of the Singapore High Court, specializes in handling IP-related cases, including patent litigation. The court has established procedures and specialized judges to ensure efficient handling of these complex cases.

Keep in mind that patent litigation can be intricate and time-consuming. Legal representation by experienced IP lawyers is often recommended to navigate the complexities of the process effectively.

Comments

Popular posts from this blog

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcur...

Corona virus (Covid-19)

The only way one can combat with Covid-19 is by building one’s immunity & staying healthy by proper hygiene Best medicines for immunity development could be multivitamin pills with zinc,and best foods could be #freshfruits #vegetables. #Mangoes #lemon #oranges are could be the best.

Biogen to seek approval for high-dose version of Spinal Muscular Atrophy stalwart Spinraza (Nusinersen) after trial win

Biogen, which was first to score an endorsement in Spinal Muscular Atrophy (SMA) in 2016, is endeavoring to address it with a higher portion variant of Spinraza #(Nusinersen). On Wednesday, the organization uncovered that a part of its stage 2/3 Commit concentrate on met its essential endpoint, as a higher portion of Spinraza worked on the engine capability of treatment-innocent newborn children with SMA. The review contrasted the high-portion routine with a coordinated, untreated hoax control bunch from the stage 3 Charm study, which empowered Spinraza's unique endorsement. In the Commit preliminary accomplice, 75 patients were randomized 2:1 to get the higher-portion routine or the FDA-endorsed dose of 12 mg, which incorporates four beginning medicines, trailed by support dosages like clockwork. While the high-portion form of Spinraza met the preliminary's endpoint contrasted with joke, the outcomes too "moved in favor" of the investigational routine contrasted with...